Launch week offerEnds in00h00m00s

annual Promonthly Pro

Catherine Alix-Panabières

Director/Professor

University Hospital of Montpellier

France

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in France Professors in Cell Biology Cell Biology professors in France

About

Dr. Catherine Alix-Panabières is an Associate Professor and Director at the University Medical Center of Montpellier, France. Her research primarily focuses on circulating tumor cells and their applications in cancer diagnosis and treatment, as highlighted in her recent articles. She explores innovative approaches in personalized oncology, liquid biopsies, and the biological mechanisms underlying immune evasion in cancer. Dr. Alix-Panabières actively contributes to advancing clinical practices through her work on prognostic indicators in various cancer types.

Articles (30)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (28)

Sia Viborg Lindskrog

Aarhus University

DENMARK

Catherine Alix-Panabières

Research Interests

Make your next move.

Explore related searches

About

Articles (30)

Decoding ctDNA: biological insights for accurate clinical interpretation

Towards liquid biopsy-based analysis of antitumour immunity

Integrating immunopeptidomics with liquid biopsy for precision oncology

Perspectives in educating molecular pathologists on liquid biopsy: Toward integrative, equitable, and decentralized precision oncology

Selection for Function in Complex Distributed Pathological Systems

Circulating tumour DNA and circulating tumour cells in bladder cancer — from discovery to clinical implementation

Prognostic significance and predictive value of circulating tumor cells in invasive lobular breast carcinoma - an exploratory analysis of the STIC CTC trial

Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis

From Discovery to Diagnosis: A Perspective for Circulating Tumor Cells in Personalized Oncology

Single-cell RNA sequencing in osteosarcoma: applications in diagnosis, prognosis, and treatment

Demographic Analysis of Cancer Research Priorities and Treatment Correlations

Aligning Cancer Research Priorities in Europe with Recommendations for Conquering Cancer: A Comprehensive Analysis

Liquid biopsy: paving a new avenue for cancer research

Surfaceome: a new era in the discovery of immune evasion mechanisms of circulating tumor cells

Cancer: Biology and Diagnostics

Circulating Tumor Cells: From Basic to Translational Research

Circulating Tumor DNA Clinical Applications in Hepatocellular Carcinoma: Current Trends and Future Perspectives

When Do Tumours Develop? Neoplastic Processes Across Different Timescales: Age, Season and Round the Circadian Clock

Baseline CTC Count as a Predictor of Long-Term Outcomes in High-Risk Prostate Cancer

Functional Analysis of Viable Circulating Tumor Cells from Triple-Negative Breast Cancer Patients Using TetherChip Technology

The effect of placentation type, litter size, lactation and gestation length on cancer risk in mammals

Circulating Tumor Cell Detection by Liquid Biopsy during Early-Stage Endometrial Cancer Surgery: A Pilot Study

Liquid Biopsy and Immuno-Oncology for Advanced Nonsmall Cell Lung Cancer

Inhibition of Wnt Signaling in Colon Cancer Cells via an Oral Drug that Facilitates TNIK Degradation

Liquid biopsy: from concept to clinical application

Mobilising Collaboration among Stakeholders to Optimise the Growing Potential of Data for Tackling Cancer

Accelerating the Development and Validation of Liquid Biopsy for Early Cancer Screening and Treatment Tailoring

Fusion Cell Markers in Circulating Tumor Cells from Patients with High-Grade Ovarian Serous Carcinoma

Detection of Circulating Tumor Cells in Cerebrospinal Fluid of Patients with Suspected Breast Cancer Leptomeningeal Metastases: A Prospective Study

Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade

Collaborators (28)

Sia Viborg Lindskrog

Etienne BRAIN

Michal Nowicki

Antoine M. Dujon

Athanasios Kotsakis

Beata Ujvari

Michail Ignatiadis

Joanna Budna-Tukan

Samantha O. Hasenleithner

Kathleen Burns

Paul Hofman

Lars Dyrskjøt

Eric Solary

Francesco Gatto

Sinead Toomey

Christophe Hirtz

Claus Lindbjerg Andersen

Reinhard Büttner

Mads Agerbaek

Justin Stebbing

Laure Cayrefourcq

Monika Świerczewska

Nuria Malats

Maciej Zabel

Massimo Cristofanilli

Carmelo Rizzari

Klaus Pantel

Gerard Eberl

Make your next move.